FDA Inspection 1307736 - Paul W. Wallace, MD - March 17, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Paul W. Wallace, MD, with an inspection on March 17, 2026, issued by the Los Angeles District Office, covering human drugs.

Company: Paul W. Wallace, MD
Inspection Date: March 17, 2026
Product Type: Human Drugs
Office: Los Angeles District Office

Open in Dashboard

ID · f6ed70f6-0bc5-4521-9c11-8fcd6786192e

Violation Codes1

21 CFR 312.60

Full citation text and observation details available on the Dashboard.